Chandra K Singh

11PUBLICATIONS
12CO-AUTHORS
Molecular targetsPredictive and prognostic markersSport and exercise nutritionInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 18, 2026
Mechanistic and preclinical evaluation of SIRT3 as a therapeutic target in melanoma.

|Jun 17, 2025
PLK4 is a potential therapeutic target in nonmelanoma skin cancers: Evidence from molecular and in vivo studies.

Mary A Ndiaye, Debra R Garvey, Gagan Chhabra

|Jan 06, 2024
Role of PLK1/NUMB/NOTCH in epithelial-mesenchymal transition in human melanoma.

Gagan Chhabra, Chandra K Singh, Mary A Ndiaye

|Mar 25, 2022
PLK4 is upregulated in prostate cancer and its inhibition reduces centrosome amplification and causes senescence.

Chandra K Singh, Ryan A Denu, Minakshi Nihal

|Jun 02, 2021
Dietary Phytochemicals in Zinc Homeostasis: A Strategy for Prostate Cancer Management.

Chandra K Singh, Gagan Chhabra, Arth Patel

|Apr 03, 2021
Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment.

Gagan Chhabra, Chandra K Singh, Deeba Amiri

Pageof 2

Frequent Collaborators

9 joint publications

Nihal Ahmad

7 joint publications

Mary Ndiaye

6 joint publications

Gagan Chhabra

2 joint publications

Shengqin Su